Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
Clinical trial NCT02461407 · UNKNOWN
Trial details
- NCT number
- NCT02461407
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-12-01
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.